Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueDepreciation ExpenseLeasesOther Gross PP&E AdjustmentsPreferred Shares IssuedProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Orchestra BioMed Holdings (OBIO) Accumulated Depreciation & Amortization (2022 - 2025)

Orchestra BioMed Holdings (OBIO) has disclosed Accumulated Depreciation & Amortization for 4 consecutive years, with $1.5 million as the latest value for Q2 2025.

  • On a quarterly basis, Accumulated Depreciation & Amortization changed N/A to $1.5 million in Q2 2025 year-over-year; TTM through Jun 2025 was $1.5 million, a N/A change, with the full-year FY2024 number at $1.3 million, up 24.81% from a year prior.
  • Accumulated Depreciation & Amortization was $1.5 million for Q2 2025 at Orchestra BioMed Holdings, up from $1.3 million in the prior quarter.
  • In the past five years, Accumulated Depreciation & Amortization ranged from a high of $1.5 million in Q2 2025 to a low of $778000.0 in Q4 2022.
  • A 4-year average of $1.1 million and a median of $1.1 million in 2023 define the central range for Accumulated Depreciation & Amortization.
  • Peak YoY movement for Accumulated Depreciation & Amortization: skyrocketed 34.19% in 2023, then increased 24.81% in 2024.
  • Orchestra BioMed Holdings' Accumulated Depreciation & Amortization stood at $778000.0 in 2022, then surged by 34.19% to $1.0 million in 2023, then rose by 24.81% to $1.3 million in 2024, then grew by 12.59% to $1.5 million in 2025.
  • Per Business Quant, the three most recent readings for OBIO's Accumulated Depreciation & Amortization are $1.5 million (Q2 2025), $1.3 million (Q4 2024), and $1.2 million (Q3 2024).